CG Oncology (NASDAQ:CGON) may offer a combination of common stock, preferred stock, debt securities, and warrants through future offerings. Source: SEC filing More on CG Oncology, Inc. A First Take On ...

Lonfin announces that, at a General Meeting held earlier today, Resolutions to approve the withdrawal of the admission of its Ordinary Shares to trading on the London Stock Exchange and to the ...

SAN DIEGO, CA / ACCESS Newswire / March 27, 2025 / Dermata Therapeutics, Inc. (NASDAQ:DRMA)(NASDAQ:DRMAW) ("Dermata," or the ...

CALGARY, AB / ACCESS Newswire / March 27, 2025 / Mkango Resources Ltd (AIM:MKA)(TSX-V:MKA) (the "Company" or "Mkango"), announces that, subject to regulatory approval, Mkango has granted 800,000 stock ...

It is hard to get excited after looking at VEEM's (ASX:VEE) recent performance, when its stock has declined 22% ...

Following the companys announcement of a 10:1 stock split, Hazoor Multi Projects Ltd.s shares experienced a significant 5% ...

Convertible securities provide financing or cash to companies in need. But their setup can be problematic if converted at ...

EDT GRI Bio (GRI) files to sell common stock, warrants, no amount givenLight Up your Portfolio with Spark:Easily identify stocks' risks ...

Manappuram Finance is in the spotlight following Capital's acquisition of an 18% stake, triggering a significant surge in the ...

Bain Capital has entered into definitive agreements to acquire joint control in Manappuram Finance, the second-largest gold ...

Under the agreement, Bain Capital will invest about Rs 4,385 crore to buy an 18 per cent stake in Manappuram Finance.